Reflect Scientific, Inc. (RSCF)
USD 0.04
(-3.37%)
USD 0.04
(-3.37%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 776.32 Thousand USD | 418.96% |
| 2022 | 149.59 Thousand USD | -50.01% |
| 2021 | 299.24 Thousand USD | -35.41% |
| 2020 | 463.3 Thousand USD | -11.88% |
| 2019 | 525.75 Thousand USD | 601.68% |
| 2018 | 74.92 Thousand USD | -39.78% |
| 2017 | 124.41 Thousand USD | 110.64% |
| 2016 | 59.06 Thousand USD | -61.06% |
| 2015 | 151.67 Thousand USD | -89.24% |
| 2014 | 1.4 Million USD | 3.89% |
| 2013 | 1.35 Million USD | 5.49% |
| 2012 | 1.28 Million USD | -71.3% |
| 2011 | 4.48 Million USD | 9.32% |
| 2010 | 4.1 Million USD | 2.66% |
| 2009 | 3.99 Million USD | 39.05% |
| 2008 | 2.87 Million USD | 82.34% |
| 2007 | 1.57 Million USD | 374.3% |
| 2006 | 332.12 Thousand USD | 41.4% |
| 2005 | 234.88 Thousand USD | -52.48% |
| 2004 | 494.3 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 816.16 Thousand USD | 5.13% |
| 2024 Q2 | 357.04 Thousand USD | -56.25% |
| 2023 FY | 776.32 Thousand USD | 418.96% |
| 2023 Q4 | 776.32 Thousand USD | 22.88% |
| 2023 Q3 | 631.76 Thousand USD | 24.08% |
| 2023 Q1 | 111.25 Thousand USD | -25.63% |
| 2023 Q2 | 509.16 Thousand USD | 357.66% |
| 2022 Q3 | 140.43 Thousand USD | -55.11% |
| 2022 Q1 | 272.72 Thousand USD | -8.86% |
| 2022 Q4 | 149.59 Thousand USD | 6.52% |
| 2022 FY | 149.59 Thousand USD | -50.01% |
| 2022 Q2 | 312.81 Thousand USD | 14.7% |
| 2021 Q2 | 406.7 Thousand USD | -14.03% |
| 2021 Q1 | 473.08 Thousand USD | 2.11% |
| 2021 FY | 299.24 Thousand USD | -35.41% |
| 2021 Q4 | 299.24 Thousand USD | 1.47% |
| 2021 Q3 | 294.89 Thousand USD | -27.49% |
| 2020 FY | 463.3 Thousand USD | -11.88% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q4 | 463.3 Thousand USD | 0.0% |
| 2019 Q4 | 525.75 Thousand USD | 65.57% |
| 2019 FY | 525.75 Thousand USD | 601.68% |
| 2019 Q3 | 317.53 Thousand USD | 130.68% |
| 2019 Q2 | 137.65 Thousand USD | -26.24% |
| 2019 Q1 | 186.62 Thousand USD | 149.07% |
| 2018 Q3 | 96.67 Thousand USD | 181.3% |
| 2018 Q4 | 74.92 Thousand USD | -22.49% |
| 2018 FY | 74.92 Thousand USD | -39.78% |
| 2018 Q1 | 55.86 Thousand USD | -55.1% |
| 2018 Q2 | 34.36 Thousand USD | -38.49% |
| 2017 FY | 124.41 Thousand USD | 110.64% |
| 2017 Q2 | 32.22 Thousand USD | 31.64% |
| 2017 Q1 | 24.47 Thousand USD | -58.56% |
| 2017 Q4 | 124.41 Thousand USD | 228.2% |
| 2017 Q3 | 37.91 Thousand USD | 17.66% |
| 2016 FY | 59.06 Thousand USD | -61.06% |
| 2016 Q4 | 59.06 Thousand USD | 25.66% |
| 2016 Q2 | 53.53 Thousand USD | -21.45% |
| 2016 Q1 | 68.15 Thousand USD | -55.07% |
| 2016 Q3 | 47 Thousand USD | -12.2% |
| 2015 Q4 | 151.67 Thousand USD | 9.9% |
| 2015 FY | 151.67 Thousand USD | -89.24% |
| 2015 Q3 | 138.01 Thousand USD | 189.65% |
| 2015 Q2 | 47.64 Thousand USD | -96.58% |
| 2015 Q1 | 1.39 Million USD | -1.16% |
| 2014 Q4 | 1.4 Million USD | -0.78% |
| 2014 Q3 | 1.42 Million USD | -0.43% |
| 2014 FY | 1.4 Million USD | 3.89% |
| 2014 Q2 | 1.42 Million USD | 2.56% |
| 2014 Q1 | 1.39 Million USD | 2.54% |
| 2013 FY | 1.35 Million USD | 5.49% |
| 2013 Q4 | 1.35 Million USD | 1.73% |
| 2013 Q3 | 1.33 Million USD | 2.23% |
| 2013 Q2 | 1.3 Million USD | 3.93% |
| 2013 Q1 | 1.25 Million USD | -2.41% |
| 2012 FY | 1.28 Million USD | -71.3% |
| 2012 Q2 | 4.72 Million USD | 2.72% |
| 2012 Q1 | 4.59 Million USD | 2.55% |
| 2012 Q3 | 1.24 Million USD | -73.71% |
| 2012 Q4 | 1.28 Million USD | 3.64% |
| 2011 Q1 | 4.25 Million USD | 3.66% |
| 2011 Q3 | 4.44 Million USD | 3.02% |
| 2011 Q2 | 4.31 Million USD | 1.57% |
| 2011 FY | 4.48 Million USD | 9.32% |
| 2011 Q4 | 4.48 Million USD | 0.79% |
| 2010 Q1 | 3.81 Million USD | -4.59% |
| 2010 Q4 | 4.1 Million USD | 0.59% |
| 2010 FY | 4.1 Million USD | 2.66% |
| 2010 Q3 | 4.07 Million USD | 5.89% |
| 2010 Q2 | 3.84 Million USD | 1.02% |
| 2009 Q3 | 4.07 Million USD | 1.69% |
| 2009 Q2 | 4.01 Million USD | 22.89% |
| 2009 Q1 | 3.26 Million USD | 13.65% |
| 2009 FY | 3.99 Million USD | 39.05% |
| 2009 Q4 | 3.99 Million USD | -2.1% |
| 2008 FY | 2.87 Million USD | 82.34% |
| 2008 Q3 | 2.39 Million USD | 1.91% |
| 2008 Q2 | 2.35 Million USD | 7.05% |
| 2008 Q1 | 2.19 Million USD | 39.62% |
| 2008 Q4 | 2.87 Million USD | 19.72% |
| 2007 Q2 | 629.35 Thousand USD | -42.32% |
| 2007 Q4 | 1.57 Million USD | 53.31% |
| 2007 FY | 1.57 Million USD | 374.3% |
| 2007 Q3 | 1.02 Million USD | 63.26% |
| 2007 Q1 | 1.09 Million USD | 228.5% |
| 2006 Q2 | 1.66 Million USD | 630.11% |
| 2006 Q3 | 709.35 Thousand USD | -57.34% |
| 2006 Q4 | 332.12 Thousand USD | -53.18% |
| 2006 Q1 | 227.75 Thousand USD | -3.04% |
| 2006 FY | 332.12 Thousand USD | 41.4% |
| 2005 FY | 234.88 Thousand USD | -52.48% |
| 2005 Q3 | 265.94 Thousand USD | -48.03% |
| 2005 Q1 | 491.91 Thousand USD | 0.0% |
| 2005 Q4 | 234.88 Thousand USD | -11.68% |
| 2005 Q2 | 511.76 Thousand USD | 4.04% |
| 2004 FY | 494.3 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | 66.963% |
| Ansell Limited | 1.32 Billion USD | 99.942% |
| Ansell Limited | 1.33 Billion USD | 99.942% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 99.386% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | 17.69% |
| Psykey, Inc. | 2.47 Million USD | 68.621% |
| ConvaTec Group Plc | 2.01 Billion USD | 99.962% |
| ConvaTec Group Plc | 2.02 Billion USD | 99.962% |
| Encision Inc. | 1.98 Million USD | 60.87% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | 74.467% |
| Innovative MedTech Inc. | 6.13 Million USD | 87.346% |
| LifePoint, Inc. | 2.45 Million USD | 68.367% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 92.375% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | 77.167% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | 74.466% |
| SmileDirectClub, Inc. | 982.26 Million USD | 99.921% |
| Sector 10, Inc. | 9.84 Million USD | 92.115% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.943% |
| SheerVision, Inc. | 1.43 Million USD | 45.764% |
| United Health Products, Inc. | 1.99 Million USD | 61.162% |
| Vasamed, Inc. | 1 Million USD | 22.776% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | 79.572% |
| Yubo International Biotech Limited | 2.91 Million USD | 73.358% |